Zynerba Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.44
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.22
|
-0.20
|
0.02
|
9.09%
|
|
2022-06-30
|
-0.23
|
-0.24
|
-0.01
|
-4.35%
|
|
2022-03-31
|
-0.23
|
-0.21
|
0.02
|
8.70%
|
|
2021-12-31
|
-0.26
|
-0.22
|
0.04
|
15.38%
|
|
2021-09-30
|
-0.25
|
-0.26
|
-0.01
|
-4.00%
|
|
2021-06-30
|
-0.24
|
-0.25
|
-0.01
|
-4.17%
|
|
2021-03-31
|
-0.25
|
-0.20
|
0.05
|
20.00%
|
|
2020-12-31
|
-0.33
|
-0.33
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.65
|
|
2021-12-31
|
-0.93
|
|
2020-12-31
|
-1.95
|
|
2019-12-31
|
-1.51
|
|
2018-12-31
|
-2.71
|
|
2017-12-31
|
-2.47
|
|
2016-12-31
|
-2.56
|
|
2015-12-31
|
-1.46
|